Safety and Efficacy Study of CENV3 Vaccine to Protect Against HCV Infection

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2012 by National Liver Institute, Egypt
Sponsor:
Information provided by (Responsible Party):
Mostafa K. El Awady, National Liver Institute, Egypt
ClinicalTrials.gov Identifier:
NCT01718834
First received: June 27, 2012
Last updated: October 30, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2013
  Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)